No matter how you work with Sleuth, you get analyses built for your question, an explorable knowledge base, and searchable documents. All from a single account.
Some work you’ll want to run yourself, and some you’ll want to hand off. Whichever way you choose, it all runs on the same knowledge base.
Included
Best if
You do
Sleuth does
You get
How it’s checked
How you buy it
Included in all four
Analysis built for your question
Explorable knowledge base
Searchable documents
Best if
You have the question and an afternoon
You do
Ask, then check the flagged cells
Sleuth does
Builds the deliverables on top of datasets built for your question
You get
The deliverable, and the data behind it
How it’s checked
Sourced and scored; you check the few flagged cells
How you buy it
Any plan, or start free
Best if
Your company already works in AI tools like Claude
You do
Ask in the chat
Sleuth does
Everything in Studio, from the chat
You get
The same deliverables, in the chat and in Studio
How it’s checked
The same as Studio
How you buy it
Any plan, or start free
Best if
You have the question and no hours
You do
Bring the question
Sleuth does
Our analysts do the work, start to finish
You get
A finished report, plus the project behind it
How it’s checked
An analyst checks the finished work
How you buy it
Scoped with us
Best if
You keep a tracker or a target list up to date by hand
You do
Set the rows, columns, and rules
Sleuth does
Builds the dataset, and keeps it current
You get
A dataset on your schedule, in your systems
How it’s checked
Built to a spec, with quality checks on every delivery
How you buy it
Scoped with us
Concierge projects and custom datasets are saved to your account, so you can ask the next question yourself.
Projects you run in AI tools like Claude are saved in Studio.
A first draft from the open web. Some of it’s wrong, and it’s difficult to tell where.
Decision-grade. Sleuth sources and scores every value, so you only look at the few flagged cells.
Production-grade. Every delivery is checked before it reaches you, so there’s nothing left for you to review.

A nine-person biotech screened 167 indications with the effort usually spent on six, in Studio, and took the work to its board and its investors.

A preclinical startup had Sleuth’s analysts screen the whole field, and learned its first angle was already closing before it pitched investors.
A health-tech company serving hospital systems
Sleuth built a dataset to its spec, checks every weekly delivery, and the company uses it inside its product.